Ravi Bhalla MD in Sun City West, Arizona

Medical School: Sorry, his university is not listed
Graduation Year: 1979
The Primary Medical Specialty for Ravi Bhalla MD is listed as: Rheumatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 45
PAC (PECOS ID)#: 3779577440
NPI #: 1174512263
NPI Created On: 10/20/2005
NPI Last Updated Listed as: 06/01/2009
Primary Taxonomy Code: 207RR0500X
License Number:
22399
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Health Net of Arizona, Inc.
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Punjabi, Indian, Hindi.

Services and Procedures include:

1. Injections of trigger points in 1 or 2 muscles
2. Injections of trigger points in 3 or more muscles
3. Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance
4. Bone density measurement using dedicated x-ray machine
5. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
7. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
8. Infusion of chemotherapy into a vein up to 1 hour
9. Infusion of chemotherapy into a vein
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Physician telephone patient service, 11-20 minutes of medical discussion
14. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
15. Injection, denosumab, 1 mg
16. Injection, methylprednisolone acetate, 20 mg
17. Injection, methylprednisolone acetate, 40 mg
18. Injection, diphenhydramine hcl, up to 50 mg
19. Injection, golimumab, 1 mg, for intravenous use
20. Injection, infliximab, excludes biosimilar, 10 mg